QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 inmed-pharmaceuticals-will-be-issued-us-patent-number-12357604-tomorrow-titled-topical-formulations-of-cannabinoids-and-use-thereof-in-the-treatment-of-pain

https://x.com/PatentGrants/status/1944848362106462423

 on-june-24-2025-inmed-pharmaceuticals-entered-agreement-to-sell-19m-shares-at-2561-each

-SEC Filing

 why-inmeds-alzheimers-drug-candidate-is-fueling-sudden-stock-surge

InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved cognit...

Core News & Articles
Market-Moving News for June 24th
06/24/2025 11:16:06

INM: 102% | InMed shares are trading higher after the company announced preclinical data showing INM-901 reduced neuroinflammat...

 inmed-pharmaceuticals-amends-standby-equity-purchase-agreement-with-yorkville-may-from-time-to-time-suspend-use-of-registration-statement-of-shares-under-sepa-with-yorkville

-SEC Filing

 why-inmed-pharmaceuticals-inm-stock-is-skyrocketing

InMed Pharmaceuticals shares are trading higher by 45% during Tuesday's session. The company announced that INM-901 reduced...

 inmed-pharmaceuticals-announces-inm-901-reduced-alzheimers-related-inflammation-achieved-statistically-significant-reduction-in-neurodegeneration-marker-neurofilament-light-chain-and-neuroinflammatory-genes-in-preclinical-study

INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer'sStatistically significant reduction in ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION